Class II Phosphoinositide 3-Kinases as Novel Drug Targets.

Falasca, Marco; Hamilton, Justin R; Selvadurai, Maria; Sundaram, Krithika; Adamska, Aleksandra; Thompson, Philip E

Falasca, Marco; Hamilton, Justin R; Selvadurai, Maria; Sundaram, Krithika; Adamska, Aleksandra; Thompson, Philip E.

Afiliação

Falasca M; Metabolic Signalling Group, School of Biomedical Sciences, CHIRI Biosciences, Curtin University , Perth, Western Australia 6845, Australia.
Hamilton JR; Australian Centre for Blood Diseases and Department of Clinical Haematology, Monash University , 99 Commercial Road, Melbourne, Victoria 3004, Australia.
Selvadurai M; Australian Centre for Blood Diseases and Department of Clinical Haematology, Monash University , 99 Commercial Road, Melbourne, Victoria 3004, Australia.
Sundaram K; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.
Adamska A; Metabolic Signalling Group, School of Biomedical Sciences, CHIRI Biosciences, Curtin University , Perth, Western Australia 6845, Australia.
Thompson PE; Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.

J Med Chem ; 60(1): 47-65, 2017 01 12.

Article em En | MEDLINE | ID: mdl-27644332

Assuntos

Inibidores de Fosfoinositídeo-3 Quinase; Animais; Doença; Inibidores Enzimáticos/farmacologia; Inibidores Enzimáticos/uso terapêutico; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Fosfoinositídeo-3 Quinase Limite: Animals / Humans Idioma: En Revista: J Med Chem Assunto da revista: QUIMICA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google